You are here

  • Home
  • Archive
  • Volume 61, Issue Suppl 2
  • PTU-013 Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopaenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD): A randomised double blinded prospective clinical pilot trial

Article info

Article menu

Download PDFPDF

Posters
Liver failure
PTU-013 Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopaenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD): A randomised double blinded prospective clinical pilot trial
Free

Authors

Citation

Basu P, Shah NJ, Farhat S, et al
PTU-013 Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopaenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD): A randomised double blinded prospective clinical pilot trial
Gut 2012;61:A187-A188.

Publication history

  • First published May 28, 2012.
Online issue publication 
April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.